Search
Free Newsletters
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
About
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
AAPL
+4.00%
$198.04
+$7.62
AMZN
+1.90%
$184.67
+$3.45
TSLA
-0.96%
$249.99
-$2.42
META
-0.59%
$543.07
-$3.22
KMX
+1.95%
$67.75
+$1.30
NYT
+0.75%
$48.23
+$0.36
WBD
-1.42%
$7.99
-$0.12
CVNA
+0.06%
$203.79
+$0.13
MSTR
+10.32%
$300.45
+$28.11
MSFT
+1.86%
$388.46
+$7.11
AAPL
+4.00%
$198.04
+$7.62
AMZN
+1.90%
$184.67
+$3.45
TSLA
-0.96%
$249.99
-$2.42
META
-0.59%
$543.07
-$3.22
KMX
+1.95%
$67.75
+$1.30
NYT
+0.75%
$48.23
+$0.36
WBD
-1.42%
$7.99
-$0.12
CVNA
+0.06%
$203.79
+$0.13
MSTR
+10.32%
$300.45
+$28.11
MSFT
+1.86%
$388.46
+$7.11
Markets
RECENT NEWS
8 key drug patents expiring soon — and what it means for the market
March 24, 2025
Trump's tariffs could exacerbate drug shortages and raise prices, industry warns
February 3, 2025
Amazon, Google, and more stocks to watch this week
February 2, 2025
Big Pharma has a big Super Bowl dilemma
February 2, 2025
Advertisement